Everand Logo

Welcome to Everand!

  • STAT

    Listen: Pharma’s response to coronavirus, Google’s appetite for health data, and biotech’s rise in China

    Does "The Art of the Deal" cover #coronavirus vaccines? Is patient privacy a relic of the past? And how big can biotech get in China?
    by Damian Garde and Rebecca Robbins and Adam Feuerstein Mar 05, 2020 1 minute

    Does “The Art of the Deal” cover vaccines? Is patient privacy a relic of the past? And how big can biotech

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
    The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
    Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
    STAT2 min readAmerican Government
    STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
    The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

    Related Books & Audiobooks